 | Yahoo! Health - My Alerts - Edit Alert |
| Thursday, Jan 31, 2013 09:03 AM EST | |
| Galectin Therapeutics Inc. Announces Submission of an Investigational New Drug (IND) Application for the Treatment of ... business-wire.com Thu, 31 Jan, 2013 06:00 AM PST Galectin Therapeutics , the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced today that it submitted an Investigational New Drug application to the US Food and Drug Administration on January 30, 2013. Charity hockey game to benefit kids with cancer Thu, 31 Jan, 2013 05:56 AM PST Area law enforcement will take on local firefighters for the annual "Guns and Hoses Charity Hockey Game" on Saturday. The event will take place at Germain Arena with former Everblades players helping the teams on the ice. Cancer Patients offered Dance Movement Therapy Classes Thu, 31 Jan, 2013 05:55 AM PST Cancer patients and survivors are invited to dance movement therapy classes Mondays beginning Feb. 18-May 13, 2013, and Tuesdays beginning Feb. 19-May 14, 2013, at the Sutter Cancer Center, 2800 L St., in midtown Sacramento. Older women targeted in cancer awareness campaign Thu, 31 Jan, 2013 05:46 AM PST AN NHS pilot campaign has been launched to urge older women who have felt bloated for more than three weeks to see a doctor immediately. Local boy with cancer given days to live fulfilling dreams thanks to charity group Thu, 31 Jan, 2013 05:45 AM PST A local boy battling cancer is getting the chance to live some of his dreams. Johnny Schutte, 10, has been given only days to live, but still finds the strength to do the things he's always wanted: ride in a fire truck, ride the incline, go bowling. Johnny's family members said he was diagnosed with a rare form of cancer, and tumors have filled his body. "Without the support of friends and ... Hiking through the desert to help Maggie's cancer care centre Thu, 31 Jan, 2013 05:39 AM PST JUST two-and-a-half years after she was diagnosed with cancer, Louise Cooper is planning an epic desert trek for charity. VG Life Sciences Reports Positive Results from First Stage of Ovarian Cancer Clinical Trial Using Sorafenib (Nexavar ... Thu, 31 Jan, 2013 05:38 AM PST SAN MARINO, Calif.--(BUSINESS WIRE)--VG Life Sciences (OTC Pink: VGLS) reports details of the successful completion of the first stage of its Phase I Trial to treat ovarian cancer. The study examines the safety and efficacy of one of VG Life Sciences’ MDT compounds, hydroxychloroquine (HCQ), in combination with an existing cancer drug, sorafenib (marketed as Nexavar™), which was co-developed by ... CytRx Receives Recommendation from Data Safety Monitoring Committee to Complete Global Phase 2b Clinical Trial with ... Thu, 31 Jan, 2013 05:37 AM PST LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, announced that the Data Safety Monitoring Committee overseeing the Company’s global Phase 2b clinical trial with tamibarotene in combination with chemotherapeutical agents as a first-line treatment for patients with advanced non-small-cell lung cancer ... Health officials say it’s important to test for radon Thu, 31 Jan, 2013 05:32 AM PST Each year, approximately 25,000 U.S. residents die of lung cancer due to radon exposure in their homes. January brings awareness to this issue through National Radon Action Month. But even though the month is coming to a close, health officials continue to urge homeowners to monitor radon levels. Novelos Therapeutics Presents Diapeutic Technology Platform At EMIT: Targeted Radiotherapy International Conference prnewswire.com Thu, 31 Jan, 2013 05:30 AM PST MADISON, Wis., Jan. 31, 2013 /PRNewswire/ -- Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that an ... | |
|
No comments:
Post a Comment